Abstract
Purpose:
To investigate the feasibility of downfield magnetic resonance spectroscopic imaging (DF-MRSI) in the human brain at 7T.
Methods:
A 7T DF-MRSI pulse sequence was implemented based on the previously described methodology at 3T, with 3D phase-encoding, spectral-spatial excitation, and frequency selective refocusing. Data were pre-processed followed by analysis using the ‘LCModel’ software package, and metabolite maps created from the LCModel results. Total scan time, including brain MRI and a water-reference MRSI, was approximately 24 minutes. The sequence was tested in 10 normal volunteers. Estimated metabolite levels and uncertainty values (Cramer Rao Lower Bounds, CRLBs) for nine downfield peaks were compared between seven different brain regions, anterior cingulate cortex (ACC), centrum semiovale (CSO),corpus callosum(CC), cerebellar vermis (CV), dorsolateral prefrontal cortex(DLPFC), posterior cingulate cortex(PCC), and Thalamus(Thal).
Results:
DF peaks were relatively uniformly distributed throughout the brain, with only a small number of peaks showing any significant regional variations. Most DF peaks had average CRLB<25% in most brain regions. Average signal-to-noise ratio (SNR) values were higher for the brain regions ACC and DLPFC (~7±0.95, mean±sd) while in a range of 3.4 – 6.0 for other brain regions. Average linewidth (FWHM) values were greater than 35Hz in the ACC, CV, and Thal, and 22Hz in CC, CSO, DLPFC, and PCC.
Conclusion:
High-field DF-MRSI is able to spatially map exchangeable protons in the human brain at high resolution and with near whole-brain coverage in acceptable scan times, and in the future may be used to study metabolism of brain tumors or other neuropathological disorders.
Introduction
Despite the fact that several biomedically interesting compounds resonate downfield (DF) from the water resonance(1), the majority of proton magnetic resonance spectroscopy (MRS) studies of the human brain over the last three decades have focused on the upfield (UF) region. There are several reasons for this, but one of the major ones is that many of the DF functional groups are exchangeable with water (e.g. amides, hydroxyls, etc.). Since standard UF MRS methods nearly always employ a pre-saturation water suppression module before MRS data acquisition, exchangeable DF resonances will also be saturated, resulting in very low signal intensities(2,3). Another challenge is that DF resonances often also have short T2 relaxation times, resulting in broad linewidths, overlapping peaks, and signal loss at longer echo times (TE)(2,4–8).
Over the last decade, methods have been developed to measure and characterize DF resonances in human brain using B0 field strengths at 3, 7, and 9.4 Tesla (T)(2,3,9–21). An important principle is to avoid pre-saturation of water in order to maintain equilibrium magnetization of exchangeable DF peaks. An early study at 3T measured the DF T1 relaxation times, that are important to know in order to optimize acquisition parameters such as TR and flip angle (2). Studies at 7 and 9.4 T reported exchange rates and T2 relaxation times of DF resonances which provide knowledge about choosing optimal echo times(9–11). Higher magnetic field strengths are known to result in increased chemical shift dispersion (measured in Hz) and signal-to-noise ratios (SNR). Also, for spin systems in slow or intermediate exchange conditions, increasing the chemical shift dispersion between the exchanging peaks should improve peak visibility (22). However, increasing B0 also has some disadvantages, such as increased linewidths (measured in Hz), potentially unfavorable changes in both T1 and T2, increased B0 and B1 field inhomogeneity, and other factors such as less efficient RF coil designs and increased RF power deposition (specific absorption rate, SAR)(22). Also, the chemical shift displacement error (CSDE) increases with higher field strength(22). Despite these potential disadvantages, multiple single voxel (SV) UF MRS studies have demonstrated improved SNR and lower uncertainty estimates (Cramer Rao Lower Bounds, CRLBs) at 7T compared to 3 or 4T(22–24). SV UF measurements at 7T have also been demonstrated to be very reproducible (25). However, there have been few studies directly comparing DF MRS measurements between different field strengths(26).
Recently, the spatial distribution of DF resonances in the human brain was mapped using a 2D DF MR spectroscopic imaging (MRSI) technique optimized for exchangeable protons(27), and further expanded to whole brain coverage using 3D phase encoding at 3T(28,29). The pulse sequence consists of a composite binomial pulse (90°) for spectral spatial excitation, and a 180° frequency refocusing pulse (Figure 1B) is designed to avoid any perturbation of the water resonance which could cause saturation of DF resonances via chemical exchange.
Figure 1.

(A) Sagittal brain MRI showing slab location and phase-encoding matrix used for 3D DF-MRSI. (B) Pulse sequence for 3D DF-MRSI implemented for 7T. The sequence consists of a spectral-spatial excitation pulse, phase-encoding gradients in 3D dimensions, and a frequency selective 180° pulse for refocusing of DF signals only. Crusher gradients are applied on all 3 gradient directions to remove artifacts, including residual water signals. Note that there is no saturation of the water signal throughout the sequence to avoid attenuation of DF resonances via chemical exchange with water.
A primary motivation for the development of DF-MRSI measurements of exchangeable protons is to be able to map brain amide levels, similar to that which may be estimated using amide proton transfer - chemical exchange saturation transfer (APT-CEST) MRI techniques(30). MRSI may offer complimentary information on amide concentrations, since it is expected to be more sensitive to slower exchanging protons than CEST (which is most sensitive for intermediate exchange rates), and also potentially less susceptible to known CEST artifacts such as non-specific magnetization transfer (MT) effects, or contrast due to changes in brain water relaxation times (31). APT-CEST has been shown in multiple studies to provide information on brain tumors, stroke, and other neuropathologies, so DF-MRSI may also be useful for diagnostic or neuroscience studies of these conditions (32–36).
In addition to providing maps of exchangeable amide protons, there is also a potential other information available from DF MRS. For instance, depending on both the acquisition techniques used and study populations, a variety of other compounds have been detected in the DF region of the spectrum; these includes peaks from homocarnosine (an inhibitory neuromodulator consisting of GABA and L-histidine)(37), L-histidine itself (detected following oral loading)(15), phenylalanine (in patients with phenylketonuria)(14), and other compounds such as glutathione and nicotinamide adenine dinucleotide (NAD+)(6,8). The DF resonances of both homocarnosine and histidine are pH sensitive, so potentially can also be used to estimate brain pH. Finally, a recent study(20) using large voxel sizes also suggested that DF MRS may be able to detect the amino acid L-tryptophan, a precursor of both the neurotransmitter serotonin and the neurohormone melatonin.
The purpose of the current study was to develop methods to map the distribution of DF signals in the human brain at 7T with whole brain coverage. Regional 7T DF-MRSI measurements were made in seven brain regions in ten healthy volunteers, including estimated DF peak concentrations, uncertainty estimates (Cramer Rao, Lower Bounds, CRLB), signal-to-noise ratios (SNR) and linewidth values. Metabolite concentrations were examined for between region differences. In addition, metabolite maps were reconstructed to visualize the spatial distribution of DF metabolites.
Methods
All participants provided written informed consent approved by the Johns Hopkins Medicine Institutional Review Board (JHMIRB). All scans were performed on a Philips 7T ‘Achieva’ scanner equipped with an 8-channel transmit/32- channel receive RF head coil (Nova Medical), spherical harmonic shim coils up to 3rd-order and a 16-channel local shim array (MRShim, GmbH, Tübingen, Germany) for optimization of B0 field homogeneity. 3D DF-MRSI was implemented as described previously at 3T (27,28), with spectral-spatial excitation and frequency selective refocusing. Briefly, as shown in Figure 1B, the spectral-spatial pulse is a composite of four individual slice selective sinc pulses with flip angles in a binomial distribution; i.e. the “1” element corresponding to an 6.875° flip angle if the overall binomial pulse corresponds to a 55° rotation (38,39). The delays between the slice selective pulses makes the binomial pulse frequency selective, exciting off-resonance magnetization while avoid perturbation of on-resonance (i.e. water) magnetization (i.e. water magnetization is returned to the Z-axis at the end of the binomial pulse (34)). Frequency selective excitation and refocusing allows for the detection of downfield signals without the presence of large residual water signals, and since the water magnetization is not saturated, there is no signal loss due to chemical exchange between water and exchangeable protons; in fact, the DF signals benefit from the relaxation enhancement (‘RE’) effect whereby their apparent T1 relaxation time is shortened by exchange with fully relaxed water (4,16,17). DF signals are mapped in 3 dimensions through the use of 3D phase-encoding. The frequency selective refocusing pulse only refocuses signals downfield from water. Crusher gradients (20 mT/m, 2 ms duration) are applied in all three spatial directions to eliminate any unwanted signals from the refocusing pulse.
Spatial resolution (i.e. field of view, voxel size, acquisition matrix size) and TR were the same as in the previous implementation at 3T (28). Because of the greater chemical shift dispersion at 7T, the inter-pulse delay was shortened from 1.45 to 0.62 msec (i.e. maximum excitation at 7.4 ppm). The frequency offset is related to δ according to:
Further, the bandwidth of the selective refocusing pulse increased from 400 to 900 Hz (~3.0 ppm), which allows TE to be shortened to 15ms compared to 22ms at 3T. Because of the shorter inter-pulse delay of the spectral-spatial excitation and slightly lower transmit B1 on the 7T system (18 μT, vs. 22 μT at 3T), the number of lobes of the slice-select pulses was decreased from 5 to 3 in order to achieve similar flip angles on both systems. The pulse width of each individual component of the spectral-spatial pulse was 0.314 ms, and their bandwidth was 13.3 kHz. A 120 mm excitation slab thickness covering from the cerebellum to the vertex was planned for each subject with a FOV of 200×180×120 mm and a matrix size 29×26×8, giving a nominal spatial resolution of ≈7×7×15 mm = 0.7 cm3. A circular region of k-space was covered using conventional, cartesian sampling (40). Circular sampling saves about 25% scan time compared to a square and also gives a spherically symmetric point-spread function (41). Other scan parameters were 1 transient, flip angle 55 °, TR 282 ms. A SENSE acceleration factor of 1.5 was used in both left-right and anterior-posterior directions resulting in a scan time of 10m 37s. All shim currents (both LC coil, and scanner spherical harmonics up to 3rd order) were calculated based on field maps over the entire volume of the brain using the ‘Arche’ software provided by MRShim. In addition to 3D DF-MRSI, an unsuppressed water MRSI was also recorded with the same voxel size and geometry as the DF sequence using a FID-MRSI sequence with flip angle 30°, TR 208 ms, TE 1 ms with a scan time of 7m 52s. Proton density (PD) localizer images, and a 3D T1w Magnetization Prepared - RApid Gradient Echo (MPRAGE) scans (42) were also performed. Total scan time was approximately 24 minutes. Finally, an imaging sequence implementing the DREAM(43,44) method for B1 mapping was performed with a nominal flip angle of 7°, a TE of 1.40 ms and TR of 3.7 ms. The protocol was tested in ten normal volunteers (5F, age 42±10 yrs).
All spectral data were exported from the scanner after channel combination and SENSE-MRSI reconstruction performed by the scanner software. Time-domain MRSI data were then processed in an automated pipeline using custom MATLAB (Mathworks, MA) software. In a pre-processing step, 4 Hz exponential filtering was applied, and DF-MRSI data were frequency corrected on a voxel-by-voxel basis using the water frequency determined from the H20-MRSI scan. Residual water was then removed using an HLSVD filter (45) in a range of 4.1 to 5.2 ppm (i.e. a frequency range of ~328 Hz) (46). DF-MRSI data were analyzed using ‘LCModel’ (47) fitting with a basis set consisting of nine Gaussian peaks ranging in frequency from 6.83 to 8.49 ppm as described previously (27,28). Water scaling was used for the LCModel concentration estimates. Due to the lack of the knowledge about the number of protons per function group, exchange rates, T1 or T2 relaxation times, no attempt was made to correct for sequence timings (TR, TE) or estimate millimolar concentrations, and results are therefore presented in ‘institutional units’ (i.u.). In addition to reporting individual values, the 3 peaks in the amide region of the spectra (8.18 to 8.37 ppm) were summed together (‘8.x’). SNR and CRLB maps were reconstructed from the LCModel output. DF maps were created using the amplitude estimates from the water-scaled LCModel output for each voxel, except when a CRLB of ‘999’ was reported, in which case the amplitude was set to zero. The LCModel control file is provided in the supplemental information.
For the reconstruction of the metabolite maps, proton density (PD) images were segmented using SPM12 (48). Metabolite maps were only computed for voxels included in the brain mask. As suggested in a recent consensus paper (49), visual interpretation of metabolite images was improved by using image interpolation factor of 8.
In each subject, up to four voxels were selected from seven representative brain regions at different locations throughout the brain: anterior cingulate cortex (ACC), dorsolateral prefrontal cortex (DLPFC), and posterior cingulate cortex (PCC) in gray matter rich regions as well as corpus collosum (CC) and centrum semiovale (CSO) in white matter, and finally cerebellar vermis (CV) and thalamus (Thal) in inferior regions. The ‘R’ Statistical Analysis Package version 3.5.1 was used for regional brain analysis (50). After log transformation, the ‘R’ generalized linear model (‘glm’) function was used to compare brain metabolite levels (i.u.) between ACC, CSO, CC, CV, DLPFC, PCC, and Thal. The independent variable is brain regions, and the dependent variable is level of metabolites. The Benjamini-Hochberg (BH) procedure (51) was used for multiple comparison correction. P values corrected with the BH procedure were presented as p-adjusted and considered significant if less than 0.05.
Results
Figure 1A shows the slab location chosen for 3D DF-MRSI in one subject, while Figure 2 shows voxel locations and representative spectra from the 7 brain regions chosen for quantitative analysis.
Figure 2.

Proton density localizer images and voxel locations of the 7 brain regions selected for quantitative analysis: cerebellar vermis (CV), left thalamus (Thal), anterior cingulate cortex (ACC), body of the corpus callosum (CC), posterior cingulate cortex (PCC), right dorsolateral prefrontal cortex (DLPFC), and left centrum semiovale (CSO) white matter. Spectra from each of these regions are plotted for 1 subject. The region analyzed by LCModel (see figure 3) is highlighted between approximately 6.5 to 9.0 ppm. The residual water signal (after removal by the HLSVD filter) can be seen at 4.7 ppm.
Figure 3 shows results of LCModel fitting for the brain regions and spectra shown in Figure 2. Figure 4 shows PD localizer images, 8.x ppm amide maps (8.1–8.3 ppm) from five slices in one subject. Spectra from 5 voxels in each slice are shown to illustrate near uniform spectral quality over this range of brain regions.
Figure 3.

LCModel fits of the 7 brain regions (figure 2) selected for quantitative analysis using nine Gaussian peaks and a baseline constrained to be relatively flat.
Figure 4.

Example amide (8.x ppm, 8.1–8.3 ppm) concentration maps and corresponding PD localizer images from five slices in one subject, with five spectra plotted from different anatomical regions from each slice. Note that this volunteer has a benign right parietal epidermal inclusion cyst (slice 7).
Figure 5 shows proton density images, amide maps and corresponding CRLB maps, SNR, LW, B0 and B1 maps over all 8 slices from one subject. Amide maps from all 10 subjects are provided in Figure S1.
Figure 5.

Proton density (PD) and amide (8.x) images, and maps of amide CRLB (range 0–20%), SNR (from LCModel, range 0–10), linewidth (LW, from water scan, range 0 to 60 Hz), B0 (range −50 to + 50 Hz) and transmit B1 maps (0 to 120% of nominal B1) from all 8 slices in one subject. More caudal slice locations are characterized by worse B0 field homogeneity and lower transmit B1, which results in lower SNR and increased linewidths and CRLB values.
Figure 6 shows estimated concentrations maps reconstructed for all nine DF peaks at 8.49, 8.37, 8.24, 8.18, 7.48, 7.30, 7.09, and 6.83 ppm in one subject.
Figure 6.

Estimated concentrations maps reconstructed for all nine DF peaks at 8.49, 8.37, 8.24, 8.18, 7.48, 7.30, 7.09, and 6.83 ppm in one subject. Note that different brightness/contrast settings are applied for each DF peak.
Figure 7 shows descriptive statistics for concentration estimates from LCModel as metabolite levels in “institutional units” and CRLB values as percentage for the nine downfield peaks and combined amide resonances (8.18–8.37 ppm) in all ten subjects from selected voxels in seven different brain regions. SNR and FWHM values from LCModel are also given for all 7 brain regions. There were no statistically significant differences between brain regions for any peak, except for DF6.83 which was significantly lower in the ACC, DLPFC, PCC, CV and CSO compared to Thal, and significantly lower in ACC than CSO (p<0.05) as well as DF8.18 was significantly different between ACC and CC, CC and DLPFC, and CC and Thal. Table S1 gives the results of statistical tests between brain regions using amide (8.x ppm) estimations from LCModel. The uncertainty estimates from LCModel (CRLB) were less than 5% for amides (8.x), DF8.18, DF7.90, and 6.83 in all brain regions except CC and CV that were less than 10% while all other CRLB values were mostly less than 25% in all brain regions except CV. Average SNR and FWHM values are also depicted in Figure 7. Average SNR, values were higher for the ACC and DLPFC regions (~7.0±0.9, mean ± s.d.) while the average SNR range was 3.4 – 6.0 with a standard deviation range of 0.97 – 1.27 for all other brain regions. Average linewidth (FWHM) values were greater than 35Hz in the ACC, CV, and Thal, and 22Hz in CC, CSO, DLPFC, and PCC.
Figure 7.

Metabolite levels (‘institutional units’) and % CRLB values for the nine downfield peaks and combined amide resonances (8.18–8.37 ppm) in all ten subjects for the seven different brain regions selected for quantitative analysis. Also shown are SNR and linewidth values for all 10 subjects as reported by LCModel.
Head specific absorption rate (SAR) and peripheral nerve stimulation (PNS) levels were <48% and 59% for the 7T DF-MRSI sequence respectively. ‘MRSinMRS’ consensus parameters are also given in the supplemental material.
Discussion
This study demonstrates that 3D DF-MRSI with 0.7 cm3 nominal voxel resolution is feasible at 7T. DF spectra have similar appearance to those previously published at 3T, however metabolite maps are somewhat less homogeneous mainly due to difficulties in achieving uniform B0 and B1 field homogeneity over the volume of the brain at high fields. Also the slab excitation profile is expected to be less rectangular than in the previous study at 3T(28) due to the reduced number of sinc lobes used in the current implementation of the excitation pulses. Regional brain analysis showed similar or lower CRLB values compared to the previous study at 3T for all DF metabolites. However, in future work, a systematic comparison between 3T and 7T should be performed with matched methodology and the same volunteers at both field strengths.
In some of the spectra, especially close to the air cavities, but also sporadically in the middle slices, we observed failed LCModel fitting with a CRLB=999 which resulted as ‘black holes’ in the final metabolite maps. As it can be seen in Figure 6, DF maps DF6.83, DF7.48, DF7.90 and DF8.18 have more black holes in lower slices (#1-#4) than the higher slices (#5-#8) as expected to due to worse field homogeneity and lower transmit B1 levels in the inferior brain regions.
Water scaling was used and maps were created relative to the brain water signal, but there are many correction factors that would need to be applied before the LCModel output could be regarded as even approximately mM concentration units; these would include correcting for T1 and T2 relaxation times, taking into account different sequence timings used for water and metabolites, and segmenting brain MRI to account for gray white, white matter, and CSF water contents in each voxel (which also affects the water relaxation times) on a voxel-by-voxel basis. Also, for molecular concentrations to be estimated, a knowledge of peak assignments and number of protons per functional group would be required.
As is well known for high field human MR systems, transmit B1 is less homogeneous than at lower field strengths (e.g. 3T or lower) and conventional amplitude-modulated RF pulses will not able to achieve a uniform flip angle for all regions of the brain. With the current 8-channel transmit head coil, B1 maps (as shown in Figure 5), indicate some central regions with higher than nominal flip angle, with lower flip angles in lateral, posterior and particularly inferior (i.e. cerebellar) brain regions. This causes signal losses in these areas in both MRI and MRSI data. In future studies, this could be corrected by the using transmit B1 maps together with knowledge of signal dependance on flip angle (52) to perform post-hoc intensity corrections.
The current study also used a 16-channel local coil (LC) shim array (in addition to the standard spherical harmonic shims on the scanner (up to 3rd order)) to improve B0 field homogeneity. Spectral quality including better linewidths and less residual water signals, particularly in more peripheral brain regions (data not shown) was clearly improved using the LC shim array, and less artifactual hyper- or hypo-intensity was noted in the amide maps. In one subject, the average magnitude water linewidth decreased from 43.1 ± 18.6 to 35.4 ± 12.9 Hz over the volume of the supratentorial brain using the LC shim array, and improvement of ~18%. Similarly, the distribution (standard deviation_ of water frequencies over the same volume decreased from 19.5 to 11.1 Hz, an improvement of ≈43%.
The present study found DF peaks to be relatively uniformly distributed throughout the brain, with only a small number of peaks showing any significant regional variations. Visual inspection of metabolite maps only shows clear reductions in signal intensity in CSF regions such as the lateral ventricles (e.g. Figures 5, 6). The lack of regional brain variations may in part be due to relatively large variance in the measurements, particularly for some of the smaller DF peaks, but also is consistent (for instance) with APT-CEST measurements of human brain protein amides, which in the normal brain are quite homogeneous and do not typically show significant regional or tissue-type variations(53). Also, maps of N-acetylaspartate (NAA, which also has a DF amide resonance) created from conventional upfield MRSI measurements are typically fairly uniform in normal brain and show little contrast between white matter and gray matter (54).
While the current study demonstrates 3D DF-MRSI at 7T with acceptable SNR, PNS and scan time, it does also have several limitations. These include a relatively small sample size, and no reproducibility measurements. In the future, accelerations methods such as sparse k-space sampling and low rank image reconstruction (55) may also be useful in further reducing scan time beyond the SENSE acceleration used here.
In conclusion, high-field DF-MRSI is able to spatially map exchangeable protons in the human brain at high resolution and with near whole-brain coverage in acceptable scan times, and in the future may be used to study metabolism of brain tumors or other neuropathological disorders.
Supplementary Material
Table S1. Table shows the results of statistical tests between brain regions using amide (8.x ppm) estimations from LCModel.
Figure S1. Reconstructed amide (8.x) maps for all ten subjects.
Acknowledgements
Supported in part by NIH grants K99EB034768, R01EB028259 and P41EB031771.
Footnotes
References
- 1.Mori S, Eleff SM, Pilatus U, Mori N, van Zijl PC. Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in situ. Magn Reson Med. 1998. Jul;40(1):36–42. [DOI] [PubMed] [Google Scholar]
- 2.MacMillan EL, Chong DG, Dreher W, Henning A, Boesch C, Kreis R. Magnetization exchange with water and T1 relaxation of the downfield resonances in human brain spectra at 3.0 T. Magn Reson Med. 2011. May;65(5):1239–46. [DOI] [PubMed] [Google Scholar]
- 3.MacMillan EL, Boesch C, Kreis R. Magnetization exchange observed in human skeletal muscle by non-water-suppressed proton magnetic resonance spectroscopy. Magn Reson Med. 2013;70(4):916–24. [DOI] [PubMed] [Google Scholar]
- 4.Goncalves SI, Ligneul C, Shemesh N. Short echo time relaxation-enhanced MR spectroscopy reveals broad downfield resonances. Magn Reson Med. 2019. Oct;82(4):1266–77. [DOI] [PubMed] [Google Scholar]
- 5.Gonçalves SI, Simões RV, Shemesh N. Short TE downfield magnetic resonance spectroscopy in a mouse model of brain glioma. Magn Reson Med. 2022;88(2):524–36. [DOI] [PubMed] [Google Scholar]
- 6.de Graaf RA, Behar KL. Detection of cerebral NAD+ by in vivo 1H NMR spectroscopy. NMR Biomed. 2014;27(7):802–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.van Zijl PCM, Zhou J, Mori N, Payen JF, Wilson D, Mori S. Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med. 2003;49(3):440–9. [DOI] [PubMed] [Google Scholar]
- 8.de Graaf RA, De Feyter HM, Brown PB, Nixon TW, Rothman DL, Behar KL. Detection of cerebral NAD+ in humans at 7T. Magn Reson Med. 2017;78(3):828–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Fichtner ND, Henning A, Zoelch N, Boesch C, Kreis R. Elucidation of the downfield spectrum of human brain at 7 T using multiple inversion recovery delays and echo times. Magn Reson Med. 2017. Jul;78(1):11–9. [DOI] [PubMed] [Google Scholar]
- 10.Fichtner ND, Giapitzakis IA, Avdievich N, Mekle R, Zaldivar D, Henning A, et al. In vivo characterization of the downfield part of (1) H MR spectra of human brain at 9.4 T: Magnetization exchange with water and relation to conventionally determined metabolite content. Magn Reson Med. 2018. Jun;79(6):2863–73. [DOI] [PubMed] [Google Scholar]
- 11.Borbath T, Murali-Manohar S, Wright AM, Henning A. In vivo characterization of downfield peaks at 9.4 T: T2 relaxation times, quantification, pH estimation, and assignments. Magn Reson Med. 2021. Feb;85(2):587–600. [DOI] [PubMed] [Google Scholar]
- 12.van Zijl PCM, Brindle K, Lu H, Barker PB, Edden R, Yadav N, et al. Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo. Curr Opin Chem Biol. 2021. Aug 1;63:209–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dziadosz M, Bogner W, Kreis R. Non-water-excitation MR spectroscopy techniques to explore exchanging protons in human brain at 3 T. Magn Reson Med. 2020. Nov;84(5):2352–63. [DOI] [PubMed] [Google Scholar]
- 14.Kreis R, Zwygart K, Boesch C, Nuoffer JM. Reproducibility of cerebral phenylalanine levels in patients with phenylketonuria determined by 1H-MR spectroscopy. Magn Reson Med. 2009. Jul;62(1):11–6. [DOI] [PubMed] [Google Scholar]
- 15.Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med. 2007. Dec;58(6):1145–56. [DOI] [PubMed] [Google Scholar]
- 16.Shemesh N, Rosenberg JT, Dumez JN, Muniz JA, Grant SC, Frydman L. Metabolic properties in stroked rats revealed by relaxation-enhanced magnetic resonance spectroscopy at ultrahigh fields. Nat Commun. 2014. Dec;5(1):4958. [DOI] [PubMed] [Google Scholar]
- 17.Shemesh N, Dumez JN, Frydman L. Longitudinal relaxation enhancement in 1H NMR spectroscopy of tissue metabolites via spectrally selective excitation. Chemistry. 2013. Sep 23;19(39):13002–8. [DOI] [PubMed] [Google Scholar]
- 18.Giapitzakis IA, Shao T, Avdievich N, Mekle R, Kreis R, Henning A. Metabolite-cycled STEAM and semi-LASER localization for MR spectroscopy of the human brain at 9.4T. Magn Reson Med. 2018. Apr;79(4):1841–50. [DOI] [PubMed] [Google Scholar]
- 19.Bagga P, Hariharan H, Wilson NE, Beer JC, Shinohara RT, Elliott MA, et al. Single-Voxel (1) H MR spectroscopy of cerebral nicotinamide adenine dinucleotide (NAD(+) ) in humans at 7T using a 32-channel volume coil. Magn Reson Med. 2020. Mar;83(3):806–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Nanga RPR, Elliott MA, Swain A, Wilson N, Swago S, Soni ND, et al. Identification of l-Tryptophan by down-field (1) H MRS: A precursor for brain NAD(+) and serotonin syntheses. Magn Reson Med. 2022. Dec;88(6):2371–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hoefemann M, Döring A, Fichtner ND, Kreis R. Combining chemical exchange saturation transfer and 1H magnetic resonance spectroscopy for simultaneous determination of metabolite concentrations and effects of magnetization exchange. Magn Reson Med. 2021;85(4):1766–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Pradhan S, Bonekamp S, Gillen JS, Rowland LM, Wijtenburg SA, Edden RAE, et al. COMPARISON OF SINGLE VOXEL BRAIN MRS AT 3T AND 7T USING 32-CHANNEL HEAD COILS. Magn Reson Imaging. 2015. Oct;33(8):1013–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mekle R, Mlynárik V, Gambarota G, Hergt M, Krueger G, Gruetter R. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med. 2009. Jun;61(6):1279–85. [DOI] [PubMed] [Google Scholar]
- 24.Tkac I, Gruetter R. Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields. Appl Magn Reson. 2005. Mar;29(1):139–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wijtenburg SA, Rowland LM, Edden RA, Barker PB. Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques. J Magn Reson Imaging. 2013. Aug;38(2):460–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Henning A, Fuchs A, Boesch C, Boesiger P, Kreis R. Downfield Spectra at Ultrahigh Field. In: ISMRM. Toronto, Canada; 2008. [Google Scholar]
- 27.Povazan M, Schar M, Gillen J, Barker PB. Magnetic resonance spectroscopic imaging of downfield proton resonances in the human brain at 3 T. Magn Reson Med. 2022. Apr;87(4):1661–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Özdemir İ, Ganji S, Gillen J, Etyemez S, Považan M, Barker PB. Downfield proton MRSI with whole-brain coverage at 3T. Magn Reson Med. 2023;90(3):814–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Özdemir İ, Kamson DO, Etyemez S, Blair L, Lin DDM, Barker PB. Downfield Proton MRSI at 3 Tesla: A Pilot Study in Human Brain Tumors. Cancers. 2023. Jan;15(17):4311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zhou J, Zaiss M, Knutsson L, Sun PZ, Ahn SS, Aime S, et al. Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors. Magn Reson Med. 2022. Aug;88(2):546–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Mueller S, Stirnberg R, Akbey S, Ehses P, Scheffler K, Stöcker T, et al. Whole brain snapshot CEST at 3T using 3D-EPI: Aiming for speed, volume, and homogeneity. Magn Reson Med. 2020. Nov;84(5):2469–83. [DOI] [PubMed] [Google Scholar]
- 32.Durmo F, Rydhög A, Testud F, Lätt J, Schmitt B, Rydelius A, et al. Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas. PLOS ONE. 2020. Dec 29;15(12):e0244003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Heo HY, Jones CK, Hua J, Yadav N, Agarwal S, Zhou J, et al. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T. J Magn Reson Imaging. 2016. Jul;44(1):41–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Jiang S, Zou T, Eberhart CG, Villalobos MAV, Heo HY, Zhang Y, et al. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI. Magn Reson Med. 2017;78(3):1100–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Jiang S, Zou T, Eberhart CG, Villalobos MAV, Heo HY, Zhang Y, et al. Predicting IDH mutation status in grade-II gliomas using amide proton transfer-weighted (APTw) MRI. Magn Reson Med. 2017. Sep;78(3):1100–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ma B, Blakeley JO, Hong X, Zhang H, Jiang S, Blair L, et al. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas: APT-MRI of Pseudo- vs. True Progression. J Magn Reson Imaging. 2016. Aug;44(2):456–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Rothman DL, Behar KL, Prichard JW, Petroff OA. Homocarnosine and the measurement of neuronal pH in patients with epilepsy. Magn Reson Med. 1997. Dec;38(6):924–9. [DOI] [PubMed] [Google Scholar]
- 38.Hore PJ. Solvent suppression in fourier transform nuclear magnetic resonance. J Magn Reson 1969. 1983. Nov 1;55(2):283–300. [Google Scholar]
- 39.Meyer CH, Pauly JM, Macovski A, Nishimura DG. Simultaneous spatial and spectral selective excitation. Magn Reson Med. 1990. Aug;15(2):287–304. [DOI] [PubMed] [Google Scholar]
- 40.Golay X, Gillen J, van Zijl PCM, Barker PB. Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain. Magn Reson Med. 2002;47(2):384–7. [DOI] [PubMed] [Google Scholar]
- 41.Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med. 1994. Jun;31(6):645–51. [DOI] [PubMed] [Google Scholar]
- 42.Brant-Zawadzki M, Gillan GD, Nitz WR. MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence--initial experience in the brain. Radiology. 1992. Mar;182(3):769–75. [DOI] [PubMed] [Google Scholar]
- 43.Nehrke K, Börnert P. DREAM—a novel approach for robust, ultrafast, multislice B1 mapping. Magn Reson Med. 2012;68(5):1517–26. [DOI] [PubMed] [Google Scholar]
- 44.Ehses P, Brenner D, Stirnberg R, Pracht ED, Stöcker T. Whole-brain B1-mapping using three-dimensional DREAM. Magn Reson Med. 2019;82(3):924–34. [DOI] [PubMed] [Google Scholar]
- 45.Cabanes E, Confort-Gouny S, Le Fur Y, Simond G, Cozzone PJ. Optimization of Residual Water Signal Removal by HLSVD on Simulated Short Echo Time Proton MR Spectra of the Human Brain. J Magn Reson. 2001. Jun;150(2):116–25. [DOI] [PubMed] [Google Scholar]
- 46.Simpson R, Devenyi GA, Jezzard P, Hennessy TJ, Near J. Advanced processing and simulation of MRS data using the FID appliance (FID-A)—An open source, MATLAB-based toolkit. Magn Reson Med. 2017;77(1):23–33. [DOI] [PubMed] [Google Scholar]
- 47.Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001. Jun;14(4):260–4. [DOI] [PubMed] [Google Scholar]
- 48.SPM Software - Statistical Parametric Mapping [Internet]. [cited 2023 Sep 12]. Available from: https://www.fil.ion.ucl.ac.uk/spm/software/
- 49.Maudsley AA, Andronesi OC, Barker PB, Bizzi A, Bogner W, Henning A, et al. Advanced magnetic resonance spectroscopic neuroimaging: Experts’ consensus recommendations. NMR Biomed. 2021. May;34(5):e4309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.The R Project for Statistical Computing. (2020). https://www.rproject.org/.
- 51.Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Methodol. 1995;57(1):289–300. [Google Scholar]
- 52.Zhu H, Soher BJ, Ouwerkerk R, Schär M, Barker PB. Spin-echo magnetic resonance spectroscopic imaging at 7 T with frequency-modulated refocusing pulses. Magn Reson Med. 2013. May;69(5):1217–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Zhou J, Heo HY, Knutsson L, van Zijl PCM, Jiang S. APT-weighted MRI: Techniques, current neuro applications, and challenging issues. J Magn Reson Imaging. 2019. Aug;50(2):347–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Maudsley AA, Domenig C, Sheriff S. Reproducibility of Serial Whole-Brain MR Spectroscopic Imaging. NMR Biomed. 2010. Apr;23(3):251–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Klauser A, Klauser P, Grouiller F, Courvoisier S, Lazeyras F. Whole-brain high-resolution metabolite mapping with 3D compressed-sensing SENSE low-rank 1H FID-MRSI. NMR Biomed. 2022;35(1):e4615. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Table S1. Table shows the results of statistical tests between brain regions using amide (8.x ppm) estimations from LCModel.
Figure S1. Reconstructed amide (8.x) maps for all ten subjects.
